Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1465 to 1474 of 1474 entries
Sorted by: Best Match Show Resources per page
Arthroscopic coracoclavicular button fixation versus anatomic locking plate fixation for unstable distal clavicular fractures.

JSES international

Erden T, Kapicioglu M, Ersen A, Toker B, Sahin K, Bilsel K.
PMID: 34505092
JSES Int. 2021 Jul 17;5(5):835-839. doi: 10.1016/j.jseint.2021.05.007. eCollection 2021 Sep.

HYPOTHESIS: Neer type II distal clavicle fractures are unstable and associated with high nonunion rates. The aim of this retrospective study was to compare the clinical and radiographic outcomes of anatomic locking plate fixation and arthroscopic coracoclavicular button fixation...

Cite
Erden T, Kapicioglu M, Ersen A, et al. Arthroscopic coracoclavicular button fixation versus anatomic locking plate fixation for unstable distal clavicular fractures. JSES Int. 2021;5(5):835-839doi: 10.1016/j.jseint.2021.05.007.
Erden, T., Kapicioglu, M., Ersen, A., Toker, B., Sahin, K., & Bilsel, K. (2021). Arthroscopic coracoclavicular button fixation versus anatomic locking plate fixation for unstable distal clavicular fractures. JSES international, 5(5), 835-839. https://doi.org/10.1016/j.jseint.2021.05.007
Erden, Tunay, et al. "Arthroscopic coracoclavicular button fixation versus anatomic locking plate fixation for unstable distal clavicular fractures." JSES international vol. 5,5 (2021): 835-839. doi: https://doi.org/10.1016/j.jseint.2021.05.007
Erden T, Kapicioglu M, Ersen A, Toker B, Sahin K, Bilsel K. Arthroscopic coracoclavicular button fixation versus anatomic locking plate fixation for unstable distal clavicular fractures. JSES Int. 2021 Jul 17;5(5):835-839. doi: 10.1016/j.jseint.2021.05.007. eCollection 2021 Sep. PMID: 34505092; PMCID: PMC8411051.
Copy Download .nbib Format: NLM
Can Age at Diagnosis and Sex Improve the Performance of the American Thyroid Association Risk Stratification System for Prediction of Structural Persistent and Recurrent Disease in Patients With Differentiated Thyroid Carcinoma? A Multicenter Study.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Zuhur SS, Aggul H, Çelik M, Avci U, Erol S, Kilinç F, Akbaba G, Cinar N, Tekin S, Sahin S, Bilen O, Elbuken G, Guldiken S, Kadioglu P, Bayraktaroglu T, Topcu B, Altuntas Y.
PMID: 34508902
Endocr Pract. 2021 Sep 08; doi: 10.1016/j.eprac.2021.09.001. Epub 2021 Sep 08.

OBJECTIVE: Although the age at diagnosis has been suggested as a major determinant of disease-specific survival in the recent TNM staging system, it is not included in the recent American Thyroid Association (ATA) guidelines to estimate the risk of...

Cite
Zuhur SS, Aggul H, Çelik M, et al. Can Age at Diagnosis and Sex Improve the Performance of the American Thyroid Association Risk Stratification System for Prediction of Structural Persistent and Recurrent Disease in Patients With Differentiated Thyroid Carcinoma? A Multicenter Study. Endocr Pract. 2021;doi: 10.1016/j.eprac.2021.09.001.
Zuhur, S. S., Aggul, H., Çelik, M., Avci, U., Erol, S., Kilinç, F., Akbaba, G., Cinar, N., Tekin, S., Sahin, S., Bilen, O., Elbuken, G., Guldiken, S., Kadioglu, P., Bayraktaroglu, T., Topcu, B., & Altuntas, Y. (2021). Can Age at Diagnosis and Sex Improve the Performance of the American Thyroid Association Risk Stratification System for Prediction of Structural Persistent and Recurrent Disease in Patients With Differentiated Thyroid Carcinoma? A Multicenter Study. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, . https://doi.org/10.1016/j.eprac.2021.09.001
Zuhur, Sayid Shafi, et al. "Can Age at Diagnosis and Sex Improve the Performance of the American Thyroid Association Risk Stratification System for Prediction of Structural Persistent and Recurrent Disease in Patients With Differentiated Thyroid Carcinoma? A Multicenter Study." Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists vol. (2021). doi: https://doi.org/10.1016/j.eprac.2021.09.001
Zuhur SS, Aggul H, Çelik M, Avci U, Erol S, Kilinç F, Akbaba G, Cinar N, Tekin S, Sahin S, Bilen O, Elbuken G, Guldiken S, Kadioglu P, Bayraktaroglu T, Topcu B, Altuntas Y. Can Age at Diagnosis and Sex Improve the Performance of the American Thyroid Association Risk Stratification System for Prediction of Structural Persistent and Recurrent Disease in Patients With Differentiated Thyroid Carcinoma? A Multicenter Study. Endocr Pract. 2021 Sep 08; doi: 10.1016/j.eprac.2021.09.001. Epub 2021 Sep 08. PMID: 34508902.
Copy Download .nbib Format: NLM
Immunogenicity of Externally Activated Nanoparticles for Cancer Therapy.

Cancers

Sahin O, Meiyazhagan A, Ajayan PM, Krishnan S.
PMID: 33260534
Cancers (Basel). 2020 Nov 28;12(12). doi: 10.3390/cancers12123559.

Nanoparticles activated by external beams, such as ionizing radiation, laser light, or magnetic fields, have attracted significant research interest as a possible modality for treating solid tumors. From producing hyperthermic conditions to generating reactive oxygen species, a wide range...

Cite
Sahin O, Meiyazhagan A, Ajayan PM, et al. Immunogenicity of Externally Activated Nanoparticles for Cancer Therapy. Cancers (Basel). 2020;12(12)doi: 10.3390/cancers12123559.
Sahin, O., Meiyazhagan, A., Ajayan, P. M., & Krishnan, S. (2020). Immunogenicity of Externally Activated Nanoparticles for Cancer Therapy. Cancers, 12(12), . https://doi.org/10.3390/cancers12123559
Sahin, Onur, et al. "Immunogenicity of Externally Activated Nanoparticles for Cancer Therapy." Cancers vol. 12,12 (2020). doi: https://doi.org/10.3390/cancers12123559
Sahin O, Meiyazhagan A, Ajayan PM, Krishnan S. Immunogenicity of Externally Activated Nanoparticles for Cancer Therapy. Cancers (Basel). 2020 Nov 28;12(12). doi: 10.3390/cancers12123559. PMID: 33260534; PMCID: PMC7760497.
Copy Download .nbib Format: NLM
Is frozen embryo transfer better than fresh embryo transfer in women undergoing intracytoplasmic sperm injection over the age of thirty-five? A single referral centre experience.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

Acet F, Hortu I, Sahin G, Goker ENT, Tavmergen E.
PMID: 33913396
J Obstet Gynaecol. 2021 Apr 29;1-5. doi: 10.1080/01443615.2021.1882973. Epub 2021 Apr 29.

Developments in embryo freezing techniques in recent years have increased the chance of pregnancy after frozen embryo transfers. In this study we aimed to compare the pregnancy outcomes between fresh (ET) and frozen-thawed embryo transfer (FET) and to evaluate...

Cite
Acet F, Hortu I, Sahin G, et al. Is frozen embryo transfer better than fresh embryo transfer in women undergoing intracytoplasmic sperm injection over the age of thirty-five? A single referral centre experience. J Obstet Gynaecol. 2021;1-5doi: 10.1080/01443615.2021.1882973.
Acet, F., Hortu, I., Sahin, G., Goker, E. N. T., & Tavmergen, E. (2021). Is frozen embryo transfer better than fresh embryo transfer in women undergoing intracytoplasmic sperm injection over the age of thirty-five? A single referral centre experience. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 1-5. https://doi.org/10.1080/01443615.2021.1882973
Acet, Ferruh, et al. "Is frozen embryo transfer better than fresh embryo transfer in women undergoing intracytoplasmic sperm injection over the age of thirty-five? A single referral centre experience." Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology vol. (2021): 1-5. doi: https://doi.org/10.1080/01443615.2021.1882973
Acet F, Hortu I, Sahin G, Goker ENT, Tavmergen E. Is frozen embryo transfer better than fresh embryo transfer in women undergoing intracytoplasmic sperm injection over the age of thirty-five? A single referral centre experience. J Obstet Gynaecol. 2021 Apr 29;1-5. doi: 10.1080/01443615.2021.1882973. Epub 2021 Apr 29. PMID: 33913396.
Copy Download .nbib Format: NLM
Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study.

Rheumatology international

Gok K, Nas K, Tekeoglu I, Sunar I, Keskin Y, Kilic E, Sargin B, Acer Kasman S, Alkan H, Sahin N, Cengiz G, Cuzdan N, Albayrak Gezer İ, Keskin D, Mulkoglu C, Resorlu H, Bal A, Duruoz MT, Kucukakkas O, Yurdakul OV, Alkan Melikoglu M, Aydin Y, Ayhan FF, Bodur H, Calis M, Capkin E, Devrimsel G, Ecesoy H, Hizmetli S, Kamanli A, Kutluk O, Sen N, Sendur OF, Tolu S, Toprak M, Tuncer T.
PMID: 34453579
Rheumatol Int. 2021 Aug 28; doi: 10.1007/s00296-021-04971-8. Epub 2021 Aug 28.

This article aims to evaluate the possible effect of obesity on quality of life, psychological status, and other clinical variables in Psoriatic arthritis (PsA). PsA patients have been recruited by the Turkish League Against Rheumatism-Network from various centers in...

Cite
Gok K, Nas K, Tekeoglu I, et al. Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study. Rheumatol Int. 2021;doi: 10.1007/s00296-021-04971-8.
Gok, K., Nas, K., Tekeoglu, I., Sunar, I., Keskin, Y., Kilic, E., Sargin, B., Acer Kasman, S., Alkan, H., Sahin, N., Cengiz, G., Cuzdan, N., Albayrak Gezer, �. �., Keskin, D., Mulkoglu, C., Resorlu, H., Bal, A., Duruoz, M. T., Kucukakkas, O., Yurdakul, O. V., Alkan Melikoglu, M., Aydin, Y., Ayhan, F. F., Bodur, H., Calis, M., Capkin, E., Devrimsel, G., Ecesoy, H., Hizmetli, S., Kamanli, A., Kutluk, O., Sen, N., Sendur, O. F., Tolu, S., Toprak, M., & Tuncer, T. (2021). Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study. Rheumatology international, . https://doi.org/10.1007/s00296-021-04971-8
Gok, Kevser, et al. "Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study." Rheumatology international vol. (2021). doi: https://doi.org/10.1007/s00296-021-04971-8
Gok K, Nas K, Tekeoglu I, Sunar I, Keskin Y, Kilic E, Sargin B, Acer Kasman S, Alkan H, Sahin N, Cengiz G, Cuzdan N, Albayrak Gezer İ, Keskin D, Mulkoglu C, Resorlu H, Bal A, Duruoz MT, Kucukakkas O, Yurdakul OV, Alkan Melikoglu M, Aydin Y, Ayhan FF, Bodur H, Calis M, Capkin E, Devrimsel G, Ecesoy H, Hizmetli S, Kamanli A, Kutluk O, Sen N, Sendur OF, Tolu S, Toprak M, Tuncer T. Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study. Rheumatol Int. 2021 Aug 28; doi: 10.1007/s00296-021-04971-8. Epub 2021 Aug 28. PMID: 34453579.
Copy Download .nbib Format: NLM
Distribution of CRISPR Types in Fluoroquinolone-Resistant .

Pathogens (Basel, Switzerland)

Adiguzel MC, Goulart DB, Wu Z, Pang J, Cengiz S, Zhang Q, Sahin O.
PMID: 33809410
Pathogens. 2021 Mar 16;10(3). doi: 10.3390/pathogens10030345.

To aid development of phage therapy against

Cite
Adiguzel MC, Goulart DB, Wu Z, et al. Distribution of CRISPR Types in Fluoroquinolone-Resistant . Pathogens. 2021;10(3)doi: 10.3390/pathogens10030345.
Adiguzel, M. C., Goulart, D. B., Wu, Z., Pang, J., Cengiz, S., Zhang, Q., & Sahin, O. (2021). Distribution of CRISPR Types in Fluoroquinolone-Resistant . Pathogens (Basel, Switzerland), 10(3), . https://doi.org/10.3390/pathogens10030345
Adiguzel, Mehmet Cemal, et al. "Distribution of CRISPR Types in Fluoroquinolone-Resistant ." Pathogens (Basel, Switzerland) vol. 10,3 (2021). doi: https://doi.org/10.3390/pathogens10030345
Adiguzel MC, Goulart DB, Wu Z, Pang J, Cengiz S, Zhang Q, Sahin O. Distribution of CRISPR Types in Fluoroquinolone-Resistant . Pathogens. 2021 Mar 16;10(3). doi: 10.3390/pathogens10030345. PMID: 33809410; PMCID: PMC8000906.
Copy Download .nbib Format: NLM
Is every other day iron supplementation effective for the treatment of the iron deficiency anemia in pregnancy?.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Karakoc G, Orgul G, Sahin D, Yucel A.
PMID: 33866933
J Matern Fetal Neonatal Med. 2021 Apr 18;1-5. doi: 10.1080/14767058.2021.1910666. Epub 2021 Apr 18.

AIM: To understand if every other day iron supplementation may be as effective as daily iron intake in anemic pregnant women.METHODS: This case-control study was conducted at a tertiary hospital in Turkey. The study randomly categorized women into two...

Cite
Karakoc G, Orgul G, Sahin D, et al. Is every other day iron supplementation effective for the treatment of the iron deficiency anemia in pregnancy?. J Matern Fetal Neonatal Med. 2021;1-5doi: 10.1080/14767058.2021.1910666.
Karakoc, G., Orgul, G., Sahin, D., & Yucel, A. (2021). Is every other day iron supplementation effective for the treatment of the iron deficiency anemia in pregnancy?. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1-5. https://doi.org/10.1080/14767058.2021.1910666
Karakoc, Gokhan, et al. "Is every other day iron supplementation effective for the treatment of the iron deficiency anemia in pregnancy?." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. (2021): 1-5. doi: https://doi.org/10.1080/14767058.2021.1910666
Karakoc G, Orgul G, Sahin D, Yucel A. Is every other day iron supplementation effective for the treatment of the iron deficiency anemia in pregnancy?. J Matern Fetal Neonatal Med. 2021 Apr 18;1-5. doi: 10.1080/14767058.2021.1910666. Epub 2021 Apr 18. PMID: 33866933.
Copy Download .nbib Format: NLM
Undenatured Type II Collagen Ameliorates Inflammatory Responses and Articular Cartilage Damage in the Rat Model of Osteoarthritis.

Frontiers in veterinary science

Orhan C, Juturu V, Sahin E, Tuzcu M, Ozercan IH, Durmus AS, Sahin N, Sahin K.
PMID: 33748207
Front Vet Sci. 2021 Mar 04;8:617789. doi: 10.3389/fvets.2021.617789. eCollection 2021.

Osteoarthritis (OA) is an age-related joint disease that includes gradual disruption of the articular cartilage and the resulting pain. The present study was designed to test the effects of undenatured type II collagen (UC-II®) on joint inflammation in the...

Cite
Orhan C, Juturu V, Sahin E, et al. Undenatured Type II Collagen Ameliorates Inflammatory Responses and Articular Cartilage Damage in the Rat Model of Osteoarthritis. Front Vet Sci. 2021;8:617789doi: 10.3389/fvets.2021.617789.
Orhan, C., Juturu, V., Sahin, E., Tuzcu, M., Ozercan, I. H., Durmus, A. S., Sahin, N., & Sahin, K. (2021). Undenatured Type II Collagen Ameliorates Inflammatory Responses and Articular Cartilage Damage in the Rat Model of Osteoarthritis. Frontiers in veterinary science, 8617789. https://doi.org/10.3389/fvets.2021.617789
Orhan, Cemal, et al. "Undenatured Type II Collagen Ameliorates Inflammatory Responses and Articular Cartilage Damage in the Rat Model of Osteoarthritis." Frontiers in veterinary science vol. 8 (2021): 617789. doi: https://doi.org/10.3389/fvets.2021.617789
Orhan C, Juturu V, Sahin E, Tuzcu M, Ozercan IH, Durmus AS, Sahin N, Sahin K. Undenatured Type II Collagen Ameliorates Inflammatory Responses and Articular Cartilage Damage in the Rat Model of Osteoarthritis. Front Vet Sci. 2021 Mar 04;8:617789. doi: 10.3389/fvets.2021.617789. eCollection 2021. PMID: 33748207; PMCID: PMC7970046.
Copy Download .nbib Format: NLM
Germline Pathogenic Variants Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma.

Journal of kidney cancer and VHL

Yalcintepe S, Gurkan H, Korkmaz FN, Demir S, Atli E, Eker D, Guler HS, Zhuri D, Atli EI, Salt SA, Sahin M, Guldiken S.
PMID: 33777662
J Kidney Cancer VHL. 2021 Mar 13;8(1):19-24. doi: 10.15586/jkcvhl.v8i1.171. eCollection 2021.

The aim of this study was to evaluate germline variant frequencies of pheochromocytoma and paraganglioma targeted susceptibility genes with next-generation sequencing method. Germline DNA from 75 cases were evaluated with targeted next-generation sequencing on an Illumina NextSeq550 instrument.

Cite
Yalcintepe S, Gurkan H, Korkmaz FN, et al. Germline Pathogenic Variants Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma. J Kidney Cancer VHL. 2021;8(1):19-24doi: 10.15586/jkcvhl.v8i1.171.
Yalcintepe, S., Gurkan, H., Korkmaz, F. N., Demir, S., Atli, E., Eker, D., Guler, H. S., Zhuri, D., Atli, E. I., Salt, S. A., Sahin, M., & Guldiken, S. (2021). Germline Pathogenic Variants Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma. Journal of kidney cancer and VHL, 8(1), 19-24. https://doi.org/10.15586/jkcvhl.v8i1.171
Yalcintepe, Sinem, et al. "Germline Pathogenic Variants Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma." Journal of kidney cancer and VHL vol. 8,1 (2021): 19-24. doi: https://doi.org/10.15586/jkcvhl.v8i1.171
Yalcintepe S, Gurkan H, Korkmaz FN, Demir S, Atli E, Eker D, Guler HS, Zhuri D, Atli EI, Salt SA, Sahin M, Guldiken S. Germline Pathogenic Variants Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma. J Kidney Cancer VHL. 2021 Mar 13;8(1):19-24. doi: 10.15586/jkcvhl.v8i1.171. eCollection 2021. PMID: 33777662; PMCID: PMC7969383.
Copy Download .nbib Format: NLM
Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer's Disease Mouse Model.

Current medicinal chemistry

Kiris I, Skalicka-Wozniak K, Basar MK, Sahin B, Gurel B, Baykal AT.
PMID: 34455957
Curr Med Chem. 2021 Aug 27; doi: 10.2174/0929867328666210827152914. Epub 2021 Aug 27.

BACKGROUND: Alzheimer's disease (AD) is one of the most prevalent diseases with rapidly increasing numbers, but there is still no medication to treat or stop the disease. Previous data on coumarins suggests that scopoletin may have potential benefits in...

Cite
Kiris I, Skalicka-Wozniak K, Basar MK, et al. Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer's Disease Mouse Model. Curr Med Chem. 2021;doi: 10.2174/0929867328666210827152914.
Kiris, I., Skalicka-Wozniak, K., Basar, M. K., Sahin, B., Gurel, B., & Baykal, A. T. (2021). Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer's Disease Mouse Model. Current medicinal chemistry, . https://doi.org/10.2174/0929867328666210827152914
Kiris, Irem, et al. "Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer's Disease Mouse Model." Current medicinal chemistry vol. (2021). doi: https://doi.org/10.2174/0929867328666210827152914
Kiris I, Skalicka-Wozniak K, Basar MK, Sahin B, Gurel B, Baykal AT. Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer's Disease Mouse Model. Curr Med Chem. 2021 Aug 27; doi: 10.2174/0929867328666210827152914. Epub 2021 Aug 27. PMID: 34455957.
Copy Download .nbib Format: NLM
Showing 1465 to 1474 of 1474 entries